CIK 0001662774
- Non-accelerated filer
- Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 901024039
- Phone
- +1 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-10 | Detke Michael J. Chief Medical Officer | Option exercise · Stock Option (right to buy) | −10,000 | 92,352 | ||
| 2021-07-07 | Detke Michael J. Chief Medical Officer | Option exercise | +17,400 | $2.23 | $39K | 17,400 |
| 2021-07-07 | Detke Michael J. Chief Medical Officer | Sale | −3,934 | $53.24 | $209K | 13,466 |
| 2021-07-07 | Detke Michael J. Chief Medical Officer | Sale | −1,648 | $54.37 | $90K | 11,818 |
| 2021-07-07 | Detke Michael J. Chief Medical Officer | Sale | −4,353 | $55.38 | $241K | 7,465 |
| 2021-07-07 | Detke Michael J. Chief Medical Officer | Sale | −6,942 | $56.27 | $391K | 523 |
| 2021-07-07 | Detke Michael J. Chief Medical Officer | Sale | −523 | $56.99 | $30K | 0 |
| 2021-07-07 | Detke Michael J. Chief Medical Officer | Option exercise · Stock Option (right to buy) | −17,400 | 102,352 | ||
| 2021-07-06 | Detke Michael J. Chief Medical Officer | Option exercise | +12,600 | $2.23 | $28K | 40,861 |
| 2021-07-06 | Detke Michael J. Chief Medical Officer | Sale | −32,313 | $53.43 | $1.7M | 8,548 |
| 2021-07-06 | Detke Michael J. Chief Medical Officer | Sale | −8,260 | $53.91 | $445K | 288 |
| 2021-07-06 | Detke Michael J. Chief Medical Officer | Sale | −288 | $55.01 | $16K | 0 |
| 2021-07-06 | Detke Michael J. Chief Medical Officer | Option exercise · Stock Option (right to buy) | −12,600 | 119,752 | ||
| 2021-06-30 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Option exercise | +30,000 | $2.23 | $67K | 30,000 |
| 2021-06-30 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Option exercise · Stock Option (right to buy) | −30,000 | 185,294 | ||
| 2021-06-28 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Option exercise | +20,000 | $2.23 | $45K | 20,000 |
| 2021-06-28 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Sale | −7,724 | $53.39 | $412K | 12,276 |
| 2021-06-28 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Sale | −7,079 | $54.13 | $383K | 5,197 |
| 2021-06-28 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Sale | −4,153 | $55.11 | $229K | 1,044 |
| 2021-06-28 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Sale | −1,044 | $56.16 | $59K | 0 |
Page 10 of 18 · 350 trades